RNA - Avidity Corp Quarterly EPS earnings growth
Avidity Biosciences (RNA) bases its efficiency on outsourcing the production of RNA drugs to external contractors. The volatility of the quarterly EPS on the GURU.Markets terminal chart clearly demonstrates the trend, where -170.80 indicates the current level. Multi-year therapy courses for rare muscle pathologies create profit potential, while the overall asset value depends on clinical test results and regulatory approvals.
%20Year-over-year%20earnings%20per%20share%20growth%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_RNA_-_Avidity-Biosciences_-_Year-over-year-earnings-per-share-growth-for-the-last-twelve-months "Avidity Biosciences, Inc. (RNA) - Quarterly EPS earnings growth from 07/04/2022 to 11/12/2026 | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for Avidity Corp (RNA)
- share price and consensus valuation forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- debt burden and liquidity indicators:
Debt to Equity Avidity Biosciences|RNA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Avidity Biosciences|RNA - Company Total Debt|Debts to Book Capitalization Avidity|RNA - Long-Term Debt Volume|Company Short-Term Debts Avidity Biosciences|Quick Liquidity aviditybiosciences.com
- earnings and valuation multiples indicators:
RNA - Company Profit|Projected Future Earnings Avidity Biosciences|RNA - Price to Earnings Ratio|Forward P/E Multiple Avidity|RNA - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avidity|RNA - Operating income before deduction of amortization|Earnings per share for the last twelve months Avidity Biosciences|RNA - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months aviditybiosciences.com|RNA - Earnings per share growth this year|Earnings growth forecast for next year Avidity Biosciences
Basic company analysis:Avidity Biosciences, Inc. - RNA
Investors are searching Avidity Biosciences (RNA) financial reports for clear markers of a transition to profitability. This metric measures the quarterly net income per share, capturing the pace of capital recovery. When analyzing the quarterly EPS chart, it is critical to avoid premature conclusions based on initial positive momentum. For the biotech sector, this indicator confirms the effectiveness of investments in RNA therapy. Growth in this figure signals the commercial success of AOC conjugate development.
Competitors of Avidity Biosciences (RNA)
TEM (Tempus AI Inc) - Year-over-year net earnings per share growth for the last 12 months|Qiagen NV - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharma) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months RGEN|Quarterly EPS earnings growth CRSP|Year-over-year net earnings per share change for the last twelve months genedx.com|Year-over-year earnings per share growth for the last twelve months Ultragenyx RARE|Beam Therapeutics Inc (BEAM) - Earnings per share growth in annualized terms for the last twelve months|SRPT - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Twist Bioscience Corp TWST|TXG: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months intelliatx.com|STOK (Stoke Therapeutics, Inc.) - Quarterly EPS earnings growth|BioLife Solutions Inc (BLFS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth WVE|MAZE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Sionna Therapeutics Inc SION|PRME: Year-over-year earnings per share growth for the last 12 months|Taysha Gene Therapies, Inc. - Quarterly EPS earnings growth|uniQure NV (QURE) - Year-over-year net earnings per share growth for the last 12 months|MGTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months REGENXBIO Corp (RGNX)|Year-over-year earnings per share growth for the last twelve months Solid Biosciences Inc.|ocugen.com (OCGN) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months PacBio (PACB)|BNTC (Benitec Biopharma Inc) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Design Pharma DSGN|RCKT: Year-over-year earnings per share growth for the last 12 months|4D Molecular Therapeutics - Quarterly EPS earnings growth|LXEO - Quarterly EPS earnings growth|KRRO: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months EDIT|Year-over-year earnings per share growth for the last twelve months Silence Therapeutics Inc.|Year-over-year earnings per share growth for the last 12 months PRQR (ProQR Therapeutics NV)|Quarterly EPS earnings growth CDXS|Quarterly EPS earnings growth sangamo.com (SGMO)|Quarterly EPS earnings growth NAUT (Nautilus Bio)|Quarterly EPS earnings growth Metagenomi Inc. MGX|DTIL: Year-over-year net earnings per share growth for the last 12 months|GBIO: Year-over-year earnings per share growth for the last twelve months|BOLD: Quarterly EPS earnings growth|XCUR - Year-over-year net earnings per share change for the last twelve months|IMNN (Imunon Inc) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months PHIO (RXi Pharmaceuticals)|Quarterly EPS earnings growth MBIO|Year-over-year net earnings per share change for the last twelve months transcodetherapeutics.com|Bionano Genomics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months APDN (adnas.com)|BLUE: Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months ImmunoPrecise Antibodies|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|Singular Genomics Corp - Year-over-year earnings per one share growth for the last 12 months|RGLS (Regulus Therapeutics) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months SYRS|Quarterly EPS earnings growth TBIO|Year-over-year net earnings per share change for the last twelve months TRACON Pharmaceuticals Inc.|Year-over-year earnings per share growth for the last twelve months Unity Bio UBX
